LEXINGTON, Mass.–(BUSINESS WIRE)–December 7, 2017–
Quanterix Company, an organization with a subsequent era, ultra-sensitive virtual platform that advances precision well being, nowadays introduced the pricing of its preliminary public providing of four,275,200 stocks of its not unusual inventory at a public providing worth of $15.00 according to proportion for mixture gross proceeds of $64,128,00zero. As well as, Quanterix has granted the underwriters a 30-day possibility to buy as much as 641,280 further stocks of not unusual inventory on the preliminary public providing worth, much less the underwriting bargain. The stocks are scheduled to start buying and selling on The Nasdaq International Marketplace underneath the ticker image “QTRX” on December 7, 2017, and the providing is anticipated to near on December 11, 2017, topic to commonplace last prerequisites.
J.P. Morgan Securities LLC, Leerink Companions LLC and Cowen and Corporate, LLC are serving as joint book-running managers for the providing. BTIG, LLC and Evercore Workforce L.L.C. are serving as co-managers.
A registration commentary on the subject of those securities used to be declared efficient by way of the Securities and Trade Fee on December 6, 2017. The providing will likely be made most effective by the use of a prospectus. A duplicate of the ultimate prospectus associated with the providing will likely be filed with the Securities and Trade Fee and could also be got, when to be had, from J.P. Morgan Securities LLC, c/o Broadridge Monetary Answers, 1155 Lengthy Island Road, Edgewood, NY 11717, phone: (866) 803-9204; Leerink Companions LLC, Consideration: Syndicate Division, One Federal Boulevard, 37th Flooring, Boston, MA 02110, by way of phone at (800) 808-7525, ext. 6132 or by way of electronic mail at email@example.com; or Cowen and Corporate, LLC, c/o Broadridge Monetary Answers, 1155 Lengthy Island Road, Edgewood, NY 11717, Attn: Prospectus Division, or by way of calling (631) 274-2806 or by way of faxing (631) 254-7140.
This press free up shall no longer represent an be offering to promote or the solicitation of an be offering to shop for, nor shall there be any sale of, those securities in any state or jurisdiction through which such be offering, solicitation or sale could be illegal previous to registration or qualification of those securities underneath the securities regulations of this kind of state or jurisdiction.
Ahead-Having a look Statements
This press free up incorporates positive forward-looking statements, together with statements in regards to Quanterix Company’s proposed preliminary public providing. Phrases similar to “expects,” “anticipates” and “intends” or equivalent expressions are meant to spot forward-looking statements. Those forward-looking statements are topic to the inherent uncertainties in predicting long term effects and stipulations and no assurance may also be for the reason that the preliminary public providing mentioned above will likely be finished at the phrases described. Finishing touch of the proposed preliminary public providing and the phrases thereof are topic to a lot of elements, a lot of that are past the keep an eye on of the Corporate, together with, with out limitation, failure of commonplace last prerequisites and the danger elements and different issues set forth within the prospectus integrated within the registration commentary, within the shape final filed with the Fee. Quanterix undertakes no legal responsibility to publicly replace or revise any forward-looking statements, whether or not as a results of new data, long term occasions or in a different way, excluding as might be required by way of regulation.
Quanterix is a corporation digitizing biomarker research with the objective of advancing the science of precision well being. The corporate’s virtual well being answer, Simoa, has the possible to switch the way in which through which healthcare is supplied nowadays by way of giving researchers the skill to intently read about the continuum from well being to illness. Quanterix’ generation is designed to permit a lot previous illness detection, higher prognoses and enhanced remedy easy methods to support the standard of existence and longevity of the inhabitants for generations to come. The generation is recently getting used for analysis packages in different healing spaces, together with oncology, neurology, cardiology, irritation and infectious illness. The corporate used to be established in 2007 and is situated in Lexington, Massachusetts.
Quanterix PR Touch:
Lauren Kaufman, 617-502-4300
Quanterix IR Touch:
Joe Driscoll, 617-301-9400
Leader Monetary Officer